30th Jun 2021 10:11 am |
RNS |
Agreement |
11th Jun 2021 9:44 am |
RNS |
Holding(s) in Company |
10th Jun 2021 3:44 pm |
RNS |
Holding(s) in Company |
9th Jun 2021 7:00 am |
RNS |
Impact of COVID-19 on Group Trading |
15th Apr 2021 5:15 pm |
RNS |
Holding(s) in Company |
6th Apr 2021 7:00 am |
RNS |
Clinigen to begin supplying Erwinase® in the UK |
24th Mar 2021 9:00 am |
RNS |
Directorate Change |
23rd Feb 2021 7:00 am |
RNS |
Half Year Results |
15th Feb 2021 7:10 am |
RNS |
Holding(s) in Company |
11th Feb 2021 7:00 am |
RNS |
Restatement of segmental reporting |
14th Jan 2021 7:00 am |
RNS |
Half Year trading update |
4th Jan 2021 7:00 am |
RNS |
Appointment of COO |
22nd Dec 2020 3:21 pm |
RNS |
Holding(s) in Company |
18th Dec 2020 7:00 am |
RNS |
Appointment of Nominated Adviser and Joint Broker |
15th Dec 2020 7:00 am |
RNS |
Holding(s) in Company |
11th Dec 2020 3:40 pm |
RNS |
Holding(s) in Company |
7th Dec 2020 10:40 am |
RNS |
Holding(s) in Company |
26th Nov 2020 4:28 pm |
RNS |
Result of AGM and Directorate Change |
26th Nov 2020 7:00 am |
RNS |
AGM statement and trading update |
23rd Nov 2020 11:08 am |
RNS |
Holding(s) in Company |
18th Nov 2020 1:41 pm |
RNS |
Holding(s) in Company |
10th Nov 2020 7:00 am |
RNS |
Totect® receives FDA approval for new indication |
30th Oct 2020 11:00 am |
RNS |
Total Voting Rights |
28th Oct 2020 7:00 am |
RNS |
Director/PDMR Shareholding |
26th Oct 2020 10:44 am |
RNS |
Holding(s) in Company |
23rd Oct 2020 1:47 pm |
RNS |
Grant of share options and PDMR notification |
14th Oct 2020 12:40 pm |
RNS |
Holding(s) in Company |
8th Oct 2020 4:00 pm |
RNS |
Issue of Equity |
5th Oct 2020 9:00 am |
RNS |
Annual Report and Notice of AGM |
29th Sep 2020 7:00 am |
RNS |
Clinigen signs MAP agreement with Synairgen |
29th Sep 2020 7:00 am |
RNS |
Synairgen and Clinigen sign Managed Access Program |
17th Sep 2020 7:00 am |
RNS |
Final Results |
16th Sep 2020 9:00 am |
RNS |
Board changes |
27th Aug 2020 12:00 pm |
RNS |
Notice of Results |
14th Jul 2020 7:00 am |
RNS |
Year end trading update |
13th Jul 2020 7:00 am |
RNS |
Aldesleukin: Orphan Drug Designation in ALS by FDA |
7th Jul 2020 3:48 pm |
RNS |
Correction: PDMR Shareholding |
7th Jul 2020 12:21 pm |
RNS |
Holding(s) in Company |
7th Jul 2020 12:15 pm |
RNS |
Holding(s) in Company |
30th Jun 2020 11:00 am |
RNS |
Total Voting Rights |